As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
Move aligns global biologics identity under the Biocon Biologics brand
With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
